In part 3 of Managing Your Career in Medical Affairs, Dr. Qasim Ahmad of Novartis describes 5 core Medical Affairs competencies MA professionals can build to demonstrate to leadership the value that Medical Affairs brings, and its strategic far reaching business impact.
Interviews are stressful, but you can reduce your adrenaline levels through proper preparation. Medical Affairs has transformed in the last decade and there are a number of key competencies which you should attempt to demonstrate through each and every contact you have with both the recruiter and your prospective employers. This article provides a list of the most desirable competencies and behaviours.
Like many things in life, when managing your career timing is everything, and being in the right place at the right time is important. Knowing whether it is the right time for you to move on is not always easy. The pharma and biotech industries are an attractive place to pursue your professional dreams, and some markets are in great demand for Medical Affairs talent. Here are a few tips on how to manage your career planning and how to get ready for your next job.
Eileen Sawyer, VP, Global Medical Affairs at uniQure, describes the importance of Medical Affairs acting as a strategic partner, how to effectively engage patients throughout the drug development process, and to ultimately achieve better patient outcomes.
Ralph Rewers, Sr Director, Global Field Medical Excellence at AbbVie, shares how Field Medical professionals are in a position to impact thousands of patients. Dr. Rewers encourages Field Medical professionals to step into the shoes of the individuals they’re speaking with to better understand their beliefs and behaviors, so organizations can better tailor medical communications to how they receive scientific data.
In this session, you will hear “insider tips” from three senior-level Medical Affairs leaders from leading multinational biopharma companies.
This podcast series discusses the basics of EUMDR, what this means more globally (FDA, CFDA) and finally – how we can view this as the golden opportunity to elevate the science of our products and communicate a compelling medical value proposition.
This MAPS podcast introduces listeners to social listening to gather insights and discusses implementation, value and technologies.
In this podcast series, panelists discuss the volatile, uncertain, complex and ambiguous (VUCA) environment that necessitates change in culture, leadership and strategy in life sciences companies. Collaboration with stakeholders are more important than ever and the real value lies in the connections between stakeholder groups. Clarity on who future internal and external stakeholders are is important for Medical Affairs functions.
In this podcast, senior leaders outline the core similarities and differences between Pharma and MedTech; assess the pros and cons of a potential move from Pharma into MedTech; and describe the practical changes required to anticipate and prepare for such a career move.